- In August 2024, Sun Pharmaceutical Industries Ltd. introduced STARIZO, an antibacterial treatment aimed at addressing Acute Bacterial Skin and Skin Structure Infections caused by drug-resistant bacteria such as MRSA in India. This medication offers the convenience of once-daily dosing for six days, simplifying the treatment regimen compared to traditional therapies that require more frequent dosing. This launch is expected to significantly improve patient compliance and treatment outcomes
- In January 2024, Pfizer Inc. formed a partnership with Glenmark Pharmaceuticals to introduce abrocitinib, marketed as CIBINQO, an oral medication for treating atopic dermatitis in India. This treatment offers rapid relief from itching and provides sustained control of the disease, enhancing the quality of life for patients suffering from this chronic skin condition. This collaboration strengthens both companies' positions in the dermatology space
- In August 2023, Arcutis Biotherapeutics, Inc. and Hangzhou Zhongmei Huadong Pharmaceutical Co., a wholly owned subsidiary of Huadong Medicine Co., Ltd., announced a strategic partnership and licensing agreement to develop, produce, and commercialize a topical solution named roflumilast in Greater China and Southeast Asia. This agreement marks a significant step in expanding access to advanced dermatological treatments in these rapidly growing markets
- In June 2023, Eli Lilly and Company revealed its decision to acquire DICE Therapeutics, Inc., aiming to enhance its immunology pipeline. This acquisition is expected to bolster Eli Lilly’s capabilities in developing novel treatments for dermatological and immunological conditions, driving future innovation in the dermatology drugs market
- In April 2023, Novartis AG received marketing authorization from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency for Cosentyx (secukinumab) to treat adults suffering from active moderate-to-severe Hidradenitis Suppurativa (HS). This approval marks a key milestone in offering effective treatment options for patients with this challenging dermatological condition
